SOX9 and non-small cell lung carcinoma: We demonstrated that PRMT7 methylated SOX9 at R160 residue, thereby antagonizing its ubiquitination and degradation mediated by KEAP1 or FBXW7, and consequently promoting NSCLC proliferation.